Table 1 Characteristics of patients receiving COVID-19 convalescent plasma at time of transfusiona
From: Hospitalized COVID-19 patients treated with convalescent plasma in a mid-size city in the Midwest
Characteristic | All patients (N = 31) |
|---|---|
Sex – no. (%) | |
 Female | 10 (32) |
 Male | 21 (68) |
BMI | 37.4 ± 10.5 |
Classification of COVID-19 Illness – no. (%) | |
 Severe | 16 (52) |
 Life-threatening | 15 (48) |
Respiratory support at time of transfusion – no. (%) | |
None | 2 (6) |
 Low-flow nasal cannula | 11 (35) |
 High-flow nasal cannula | 8 (26) |
 Mechanical ventilation | 10 (32) |
Sequential Organ Failure Assessment (SOFA) Score | 2 [4] |
C-reactive protein – mg/dL | 15.5 ± 9.5 |
D-dimer – mcg/mL | 2.6 ± 4.0 |
Ferritin – ng/mL | 1532 ± 1414 |
Hospital length of stay in days | 12 [22] |
Days from CP transfusion to discharge | 7 [14] |
Final disposition – no. (%) | |
 Home | 15 (48%) |
 Inpatient rehabilitation then home | 2 (7%) |
 Skilled nursing facility or long-term care | 5 (5%) |
 Dead | 4 (13%) |
 Ongoing inpatient care | 5 (16%) |